Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001390454 | SCV001592194 | pathogenic | not provided | 2020-02-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys339*) in the F11 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs745901569, ExAC 0.02%). This variant has not been reported in the literature in individuals with F11-related conditions. Loss-of-function variants in F11 are known to be pathogenic (PMID: 23929304). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001390454 | SCV005383008 | uncertain significance | not provided | 2024-01-17 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge |